Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 58.20 | 68.68 | — | — | 44.24 | 33.71 | 22.61 | 42.65 | 54.25 | 49.16 | 61.34 | — | 44.97 | 47.42 | 27.82 | 101.29 | 26.40 | 31.38 | 26.73 | 32.72 | 41.89 |
| — | +103.8% | — | — | -18.4% | -31.4% | -63.1% | — | +20.6% | +3.7% | +120.5% | — | +70.4% | +51.1% | +4.0% | +209.5% | -37.0% | -11.2% | -92.8% | +9.9% | +63.9% | |
| P/S Ratio | 1.61 | 1.86 | 1.43 | 1.46 | 1.97 | 1.81 | 1.79 | 1.85 | 1.90 | 2.08 | 2.72 | 2.25 | 2.29 | 2.75 | 2.15 | 1.87 | 1.77 | 2.52 | 2.44 | 2.38 | 2.84 |
| — | +3.0% | -20.1% | -21.1% | +3.7% | -13.1% | -34.1% | -17.9% | -17.1% | -24.2% | +26.8% | +20.8% | +29.4% | +8.9% | -12.1% | -21.5% | -37.6% | -14.3% | -18.1% | -27.8% | +10.7% | |
| P/B Ratio | 1.63 | 1.36 | 1.45 | 1.54 | 1.65 | 1.55 | 1.44 | 1.76 | 1.90 | 2.08 | 2.52 | 2.14 | 2.06 | 2.54 | 2.64 | 2.17 | 2.12 | 3.08 | 2.80 | 2.73 | 3.33 |
| — | -12.7% | +0.7% | -12.6% | -13.2% | -25.3% | -42.8% | -17.7% | -7.5% | -18.2% | -4.3% | -1.6% | -2.8% | -17.6% | -5.7% | -20.3% | -36.4% | -11.7% | -13.2% | -27.7% | +21.0% | |
| P/FCF | 20.62 | 9.46 | — | 14.10 | 20.67 | 9.40 | — | 19.74 | 16.28 | 12.98 | 164.18 | 14.18 | 24.88 | 16.68 | 34.32 | 16.12 | 22.45 | 25.67 | 35.26 | 22.51 | 16.04 |
| — | +0.6% | — | -28.6% | +27.0% | -27.6% | — | +39.3% | -34.6% | -22.1% | +378.4% | -12.0% | +10.8% | -35.0% | -2.7% | -28.4% | +39.9% | +11.2% | +69.2% | +35.5% | +45.9% | |
| EV / EBITDA | 16.03 | 10.74 | 17.56 | 14.78 | 12.59 | 11.77 | 13.36 | 19.66 | 18.47 | 19.16 | 23.91 | 116.12 | 18.74 | 18.48 | 18.55 | 31.11 | 16.36 | 17.35 | 19.73 | 18.28 | 19.34 |
| — | -8.8% | +31.4% | -24.8% | -31.8% | -38.6% | -44.1% | -83.1% | -1.4% | +3.7% | +28.9% | +273.3% | +14.5% | +6.5% | -6.0% | +70.2% | -15.4% | +7.9% | -2.5% | -6.9% | +47.9% | |
| EV / EBIT | 20.49 | — | 27.54 | 22.75 | 15.51 | 14.55 | 17.38 | 19.52 | 24.62 | 22.94 | 27.19 | 177.42 | 20.80 | 20.32 | 22.74 | 48.44 | 16.82 | 19.95 | 23.22 | 19.22 | 21.21 |
| — | — | +58.5% | +16.6% | -37.0% | -36.5% | -36.1% | -89.0% | +18.4% | +12.9% | +19.6% | +266.3% | +23.7% | +1.9% | -2.1% | +152.0% | -20.7% | +10.5% | -2.3% | +10.8% | +46.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.1% | 33.0% | 14.5% | 20.7% | 22.5% | 25.4% | 20.4% | 18.7% | 17.3% | 20.3% | 18.2% | 19.7% | 18.6% | 21.3% | 20.8% | 19.7% | 19.2% | 21.9% | 20.2% | 20.9% | 23.7% |
| — | +30.3% | -29.0% | +10.6% | +29.7% | +25.2% | +11.6% | -5.3% | -6.9% | -4.7% | -12.2% | +0.0% | -3.0% | -3.0% | +2.9% | -5.8% | -18.9% | -18.9% | -12.4% | -15.5% | -15.1% | |
| Operating Margin | 10.3% | 15.8% | 7.5% | 10.9% | 15.4% | 15.2% | 12.9% | 8.1% | 8.8% | 9.3% | 9.6% | -0.6% | 10.6% | 13.2% | 11.4% | 4.8% | 10.7% | 14.3% | 11.4% | 12.7% | 13.4% |
| — | +3.7% | -41.5% | +34.7% | +76.0% | +63.1% | +34.3% | +1517.2% | -17.1% | -29.7% | -16.2% | -111.8% | -0.8% | -7.2% | +0.3% | -62.1% | -20.7% | -18.5% | -14.6% | -18.2% | -26.5% | |
| Net Margin | 1.9% | 7.1% | -2.2% | -5.2% | 4.4% | 5.4% | 6.5% | 4.1% | 3.3% | 4.1% | 4.2% | -5.1% | 4.7% | 5.3% | 5.1% | -0.8% | 6.7% | 8.1% | 6.6% | 7.0% | 6.7% |
| — | +32.4% | -133.7% | -226.2% | +34.2% | +30.4% | +52.9% | +180.6% | -29.6% | -22.6% | -16.3% | -562.7% | -30.3% | -34.1% | -22.8% | -111.0% | -0.3% | -2.8% | +716.9% | +13.9% | +10.7% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.0% | 1.3% | -0.6% | -1.4% | 0.9% | 1.2% | 1.3% | 1.0% | 0.8% | 1.0% | 1.0% | -1.2% | 1.1% | 1.4% | 1.6% | -0.2% | 2.0% | 2.5% | 1.9% | 2.1% | 2.0% |
| — | +10.5% | -142.8% | -230.6% | +13.4% | +12.7% | +30.7% | +186.7% | -22.1% | -27.4% | -35.8% | -423.4% | -47.5% | -42.7% | -17.9% | -111.1% | +2.2% | -1.2% | +766.7% | +16.5% | +19.3% | |
| ROA | 1.3% | 0.8% | -0.4% | -0.9% | 0.6% | 0.7% | 0.8% | 0.7% | 0.5% | 0.7% | 0.7% | -0.8% | 0.7% | 0.9% | 0.9% | -0.1% | 1.2% | 1.5% | 1.1% | 1.3% | 1.4% |
| — | +6.3% | -142.0% | -229.8% | +13.1% | +10.7% | +28.6% | +185.8% | -22.8% | -21.8% | -24.8% | -500.2% | -40.5% | -40.7% | -23.7% | -110.0% | -13.2% | -15.7% | +654.8% | +6.7% | +18.5% | |
| ROIC | 5.6% | 1.6% | 1.0% | 1.5% | 1.8% | 1.8% | 1.4% | 1.2% | 1.4% | 1.4% | 1.4% | -0.1% | 1.6% | 2.0% | 1.7% | 0.7% | 1.6% | 2.3% | 1.7% | 2.1% | 2.3% |
| — | -10.5% | -31.8% | +24.2% | +33.1% | +25.1% | +0.2% | +1495.7% | -12.1% | -27.5% | -15.3% | -112.1% | -5.1% | -11.3% | -1.3% | -65.8% | -30.0% | -29.0% | -23.7% | -27.0% | -25.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.22 | 0.46 | 0.55 | 0.39 | 0.40 | 0.40 | 0.39 | 0.38 | 0.39 | 0.38 | 0.40 | 0.39 | 0.40 | 0.62 | 0.61 | 0.56 | 0.57 | 0.49 | 0.49 | 0.32 |
| — | -44.0% | +14.5% | +42.2% | +3.9% | +3.2% | +6.1% | -1.9% | -2.7% | -3.0% | -38.4% | -35.0% | -31.0% | -30.4% | +26.2% | +23.6% | +77.6% | +82.1% | +83.9% | +82.1% | +29.6% | |
| Debt / EBITDA | 4.14 | 6.21 | 17.32 | 15.98 | 9.90 | 9.85 | 12.05 | 14.60 | 13.29 | 12.90 | 13.48 | 79.98 | 13.12 | 10.93 | 14.41 | 27.90 | 14.21 | 11.19 | 11.97 | 11.42 | 6.83 |
| — | -37.0% | +43.8% | +9.5% | -25.6% | -23.6% | -10.6% | -81.7% | +1.3% | +18.0% | -6.5% | +186.7% | -7.7% | -2.3% | +20.4% | +144.3% | +108.2% | +108.1% | +90.9% | +112.6% | +55.5% | |
| Current Ratio | 1.01 | 1.27 | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 | 1.30 | 1.30 | 1.39 | 1.43 | 1.08 | 1.14 | 0.97 |
| — | +7.5% | +1.0% | -14.9% | -32.3% | -37.2% | -45.6% | -48.2% | -36.0% | -33.2% | +66.3% | +75.5% | +100.3% | +96.8% | +20.4% | +14.2% | +42.5% | +35.4% | +29.0% | +21.6% | +9.7% | |
| Quick Ratio | 1.01 | 1.27 | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 | 1.30 | 1.30 | 1.39 | 1.43 | 1.08 | 1.14 | 0.97 |
| — | +7.5% | +1.0% | -14.9% | -32.3% | -37.2% | -45.6% | -48.2% | -36.0% | -33.2% | +66.3% | +75.5% | +100.3% | +96.8% | +20.4% | +14.2% | +42.5% | +35.4% | +29.0% | +21.6% | +9.7% | |
| Interest Coverage | 9.23 | 2.50 | 4.78 | 7.36 | 10.50 | 10.35 | 8.60 | 9.94 | 7.11 | 8.47 | 8.50 | 1.05 | 8.51 | 8.25 | 6.62 | 3.04 | 8.97 | 20.75 | 29.67 | 97.28 | 67.93 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying USPH stock.
U.S. Physical Therapy, Inc.'s current P/E is 58.2x. The average P/E over the last 2 quarters is 56.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
U.S. Physical Therapy, Inc.'s current operating margin is 10.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking U.S. Physical Therapy, Inc.'s business trajectory between earnings reports.